Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 100 participants.
Also called NCT02916485
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02916485
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- India
- Registry status
- Suspended
Technical summary
Registry record NCT02916485. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06 (anticipated); primary completion 2018-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold
- Acronym
- BIOSOLVE-India
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Bioresorbable scaffold
- Lead sponsor
- Biotronik AG
- Collaborator
- CBCC-VIBGYOR Research Pvt. Ltd.
Record details
- Record id
cardio:ct-nct02916485- Content hash
643ab46d5680097e9b50fa5c35bf291beb8f819d4f670c2a2aaa0054a17f2d0c